Solventum Corp reported $4.81B in Operating Expenses for its fiscal quarter ending in September of 2026.





Operating Expenses Change Date
Abbott USD 11.66B 1.2B Sep/2026
Align Technology USD 821.72M 43.15M Sep/2026
Baxter International USD 6.5B 3.82B Sep/2026
Becton, Dickinson and Co. USD 4.16B 20.25B Sep/2026
Cencora USD 83.54B 6.54B Jun/2026
Dexcom USD 990.1M 53.5M Jun/2026
Insulet USD 652.2M 19.8M Sep/2026
Solventum Corp USD 4.81B 5M Sep/2026
West Pharmaceutical Services USD 2.97B 22M Sep/2026
Zimmer Biomet Holdings USD 1.72B 110.9M Sep/2026